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 Background: Depressive disorder, including recurrent type (rDD), is accompanied by increased oxidative stress and activa-
tion of inflammatory pathways, which may induce DNA damage. This thesis is supported by the presence of 
increased levels of DNA damage in depressed patients. Such DNA damage is repaired by the base excision re-
pair (BER) pathway. BER efficiency may be influenced by polymorphisms in BER-related genes. Therefore, we 
genotyped nine single-nucleotide polymorphisms (SNPs) in six genes encoding BER proteins.
 Material/Methods: Using TaqMan, we selected and genotyped the following SNPs: c.-441G>A (rs174538) of FEN1, c.2285T>C 
(rs1136410) of PARP1, c.580C>T (rs1799782) and c.1196A>G (rs25487) of XRCC1, c.*83A>C (rs4796030) and 
c.*50C>T (rs1052536) of LIG3, c.-7C>T (rs20579) of LIG1, and c.-468T>G (rs1760944) and c.444T>G (rs1130409) 
of APEX1 in 599 samples (288 rDD patients and 311 controls).
 Results: We found a strong correlation between rDD and both SNPs of LIG3, their haplotypes, as well as a weaker as-
sociation with the c.-468T>G of APEXI which diminished after Nyholt correction. Polymorphisms of LIG3 were 
also associated with early onset versus late onset depression, whereas the c.-468T>G polymorphism showed 
the opposite association.
 Conclusions: The SNPs of genes involved in the repair of oxidative DNA damage may modulate rDD risk. Since this is an ex-
ploratory study, the results should to be treated with caution and further work needs to be done to elucidate 
the exact involvement of DNA damage and repair mechanisms in the development of this disease.
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Background
Inflammation is present in patients with depressive disorders, 
including recurrent depressive disorder (rDD), and is thought 
to play an important role in the risk for and pathogenesis of 
this disease [1,2]. The presence of inflammation is indicated 
by the elevated levels of pro-inflammatory cytokines such as 
interleukin-1b (IL-1b) and interleukin-8 (IL-8), and by increased 
expression of NOD-like receptor family, pyrin domain contain-
ing 3 (NLRP3), one of the NOD-like receptors, which is a com-
ponent of inflammasome which is necessary for the release of 
IL-1b and IL-18 [3–6]. In depression, inflammation is often ac-
companied by increased oxidative stress, since increased lip-
id peroxidation and production of mitochondrial reactive ox-
ygen species (mtROS) are found in depressed patients [6,7]. 
ROS may damage biomolecules, including genetic material, as 
indicated by elevated levels of 8-oxoguanine (8-oxoG), a mark-
er of oxidative DNA damage, in patients with clinical depres-
sion as well as depression that coexists with other non-mental 
diseases [8–13]. Depression severity may be a factor as well 
in milder, non-clinical depression, although 8-oxoG levels do 
not differ from controls [14]. Our team has confirmed previ-
ous study results that showed increased levels of oxidative-
ly modified purines and pyrimidines, as well as DNA strand 
breaks and alkali labile sites in peripheral blood mononucle-
ar cells (PBMCs) isolated from patients with rDD, using comet 
assay [15]. Furthermore, a recent report showed that NRLP3 
may regulate the DNA damage response, with NRLP3 knock-
out increasing the expression of proteins involved in base-ex-
cision repair (BER) in murine dendritic cells exposed to geno-
toxic and oxidative stress [16]. In a previous study, we showed 
that PBMCs of rDD patients’ cells repaired DNA damage in-
duced by hydrogen peroxide (H2O2) less efficiently than in con-
trol patients’ cells [15]. Finally, our team genotyped single nu-
cleotide polymorphism (SNPs) of glycosylases involved in the 
first step of BER, finding that their polymorphisms may mod-
ulate rDD risk [17].
The aforementioned studies indicate that depression may be 
associated with impairment of the DNA damage repair mech-
anism, more particularly the pathways involved in the repair 
of oxidative DNA damage such as BER. Accordingly, we chose 
to study the relationship between rDD occurrence and SNPs of 
genes encoding proteins involved in BER, namely: c.-441G>A 
(rs174538) of FEN1 (flap structure-specific endonuclease 1); 
c.2285T>C (rs1136410) of PARP1 (poly [ADP-ribose] poly-
merase 1); c.580C>T (rs1799782) and c.1196A>G (rs25487) of 
XRCC1 (X-ray repair cross-complementing protein 1); c.*83A>C 
(rs4796030) and c.*50C>T (rs1052536) of LIG3 (DNA ligase 
3); c.-7C>T (rs20579) of LIG1 (DNA ligase 1); and c.-468T>G 
(rs1760944) and c.444T>G (rs1130409) of APEX1 (APEX nu-
clease 1, DNA-[apurinic or apyrimidinic site] lyase).
Material and Methods
Study subjects
The study included 599 participants: patients with rDD (n=288, 
140 women and 148 men; mean age 49.3±10.2) and healthy con-
trols (n=311, 153 women and 158 men; mean age 51.2±13.3). 
All patients were hospitalized at the Department of Adult 
Psychiatry of the Medical University of Lodz (Poland) and were 
randomly recruited for this study without replacement sampling, 
based on the inclusion criteria for a current episode of depres-
sion and rDD outlined in ICD-10 (F32.0–7.32.2, F33.0–F33.8) 
[18] and a written informed consent to participate in the study. 
The diagnosis of rDD was established according to ICD-10 cri-
teria. In all qualified cases, medical history was obtained using 
the standardized Composite International Diagnostic Interview 
(CIDI) [19]. Exclusion criteria included: the presence of axis I 
and II disorders other than depressive episodes, a diagnosis 
of severe and chronic somatic diseases or worsening of symp-
toms, injuries of the central nervous system, and inflammato-
ry or autoimmune disorders. The control group was selected 
randomly from respondents with a negative history of mental 
illness. The control group included community volunteers en-
rolled in the study following the criteria of the psychiatric CIDI 
interview as well as depressed patients who were not treated 
for any severe and chronic diseases or worsening of symptoms, 
injuries of the central nervous system, or inflammatory or auto-
immune disorders. An informed, written consent for participa-
tion in the study was obtained from each participant, accord-
ing to the protocol approved by the Bioethics Committee of the 
Medical University of Lodz (No. RNN/70/14/KE).
Selection of single-nucleotide polymorphisms
We selected the studied polymorphisms from the public domain 
of the National Center for Biotechnology Information, Single 
Nucleotide Polymorphisms database (NCBI dbSNP) at http://
www.ncbi.nlm.nih.gov/snp (Bethesda, MD, USA). We chose SNPs 
with a minor allele frequency larger than 0.05 in a European 
population (submitter population ID: HapMap-CEU), that are 
frequently studied in the literature and which are either local-
ized in coding regions causing non-synonymous substitution or 
in regulatory regions. Finally, we selected nine polymorphisms: 
• c.-441G>A localized near 5’ end of FEN1;
•  c.2285T>C localized in exon of PARP1 causing valine to ala-
nine substitution in codon 762;
•  c.580C>T and c.1196A>G localized in exon of XRCC1 causing 
arginine to tryptophan substitution in codon 194 and glu-
tamine to arginine substitution in codon 399, respectively;
•  c.*83A>C and c.*50C>T localized in untranscribed region at 
3’ end (UTR-3) of LIG3;
•  c.-7C>T localized in untranscribed region at 5’ end (UTR-5) 
of LIG1;
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•  c.-468T>G and c.444T>G localized near 5’ end and in exon 
causing asparagine to glutamic acid in codon 148, respec-
tively, in APEX1.
Extraction of DNA and genotyping
Blood Mini Kit (A&A Biotechnology, Gdynia, Poland) was used 
to extract genomic DNA from venous blood. Sample purity was 
obtained by calculating absorbance ratio at 260 nm and 280 nm.
Chosen SNPs were genotyped using TaqMan® SNP Genotyping 
Assay and TaqMan Fast Universal PCR Master mix (Life 
Technologies, Carlsbad, CA, USA) in conditions recommended 
by the manufacturer. We used Bio-Rad CFX96 Real-Time PCR 
Detection System to carry out reactions. The analysis was done 
with CFX Manager Software (both from Bio-Rad Laboratories 
Inc., Hercules, California, USA).
Statistical analysis
Analysis of gathered data was performed in SigmaPlot 11.0 
and Statistica 12 (Systat Software Inc., San Jose, CA, USA and 
Statsoft, Tulsa, OK, USA, respectively). Agreement with Hardy-
Weinberg equilibrium (HWE) of the studied SNPs’ genotype 
frequencies was checked using the chi-square test. An uncon-
ditional multiple logistic regression model was used to evalu-
ate the association between case/control and each polymor-
phism or the gene–gene interactions by measuring the odds 
ratio (OR) and its corresponding 95% confidence interval (CI). 
We used multi-variable logistic regression model (fractional 
polynomials) to evaluate the independent relationship between 
the studied variants and the presence of depression disorder 
adjusting for age covariates to prevent loss of information re-
sulting from age dichotomization. For multiple testing correc-
tion, we calculated the effective number of independent tests 
using Single Nucleotide Polymorphism Spectral Decomposition 
(SNPSpD) method which is based on the spectral decomposi-
tion (SpD) of matrices of pair-wise linkage disequilibrium val-
ues between SNPs [20] applying significance threshold (p<0.012) 
calculated by the method described by Li and Ji [21]. Although 
the distribution of male and female did not differ between the 
patients and controls (p=0.951; c2=0.004), the OR was adjust-
ed for gender, given that women have a doubled risk of depres-
sion compared to men [22].
Results
Single-nucleotide polymorphisms of studied genes and the 
risk of recurrent depressive disorder
The genotyping of the studied SNPs are presented in Table 1. 
The distribution of all genotypes was in agreement with HWE, 
with the exception of the c.-441G>A – FEN1. We did not find 
any statistically significant differences in the distribution of 
alleles and the genotype of c.-441G>A – FEN1, c.2285T>C – 
PARP1, c.580C>T – XRCC1, c.1196A>G – XRCC1, c.-7C>T – LIG1, 
and c.444T>G – APEX1 between cases and controls. However, 
genotype A/A and allele A of the c.*83A>C – LIG3 was associ-
ated with an increased risk of depression occurrence, whilst 
allele C was associated with decreased risk. Furthermore, gen-
otype C/C and allele C of the c.*50C>T – LIG3 were positively 
associated with rDD, with allele T being negatively correlated 
with rDD. Finally, we found that genotype T/G of the c.-468T>G 
– APEX1 was associated with an increased risk of depression. 
It must be noted, that the p values for alleles of c.*50C>T – 
LIG3 and heterozygotes of c.-468T>G – APEX1 were greater 
that the statistical significance calculated by the Nyholt cor-
rection (p=0.012).
Single-nucleotide polymorphisms of studied genes and 
onset age of first episode of recurrent depressive disorder
In order to evaluate if the studied SNPs were associated with 
the age of the first rDD episode, we used multivariable logis-
tic regression for analyzing fractional polynomials. We found 
that lower age of onset of depression was associated with the 
presence of G/G polymorphic variant of c.-441G>A FEN1 poly-
morphism (c2=8.47, p=0.042) and G/G variant of c.-7C>T LIG1 
polymorphism (c2=6.45, p=0,045). For the other study SNPs, 
we did not find statistically significant correlations with age 
of onset. Moreover, we analyzed the relationship between the 
presence of polymorphic variants and age of onset by divid-
ing the patients into two groups, with first episode before the 
age 35 years and first episode after the age of 35 years (op-
timal cutpoint in a univariate analysis); results are shown in 
Table 2. Thirty patients for whom age of first episode was un-
known were not included in the analysis. As with the popula-
tion of patients as a whole, no statistically significant differenc-
es were found in the distribution of genotypes and alleles of 
the c.-441G>A – FEN1, c.2285T>C – PARP1, c.580C>T – XRCC1, 
c.1196A>G – XRCC1, c.-7C>T – LIG1, and c.444T>G – APEX1 be-
tween the controls and either early or late onset depression. 
Genotype A/A of the c.*83A>C – LIG3 was associated with in-
creased risk of both early and late onset depression, whilst al-
lele A was associated with an increased risk of early onset de-
pression only. Furthermore, genotype C/C and allele C of the 
same SNP was associated with a decreased risk of early onset 
depression. In the case of the c.*50C>T – LIG3, genotype C/C 
and allele C were positively correlated with early onset rDD, 
and allele T negatively correlated. Finally, the T/G genotype of 
the c.-468T>G – APEX1 increased the risk of early onset de-
pression, while allele T increased the risk of late onset depres-
sion, with the G/G genotype and allele G decreasing this risk.
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Genotype
/Allele
Control
(n=311)
Depression
(n=288) Crude OR 
(95% CI)
p
Adjusted OR
(95% CI)*
p
Number Frequency Number Frequency
c.-441G>A – FEN1 (rs174538)
A/A 0 – 0 – – – – –
A/G 151 0.486 119 0.413 0.746 (0.540–1.031) 0.076 0.746 (0.540–1.030) 0.075
G/G 160 0.514 169 0.587 1.340 (0.970–1.852) 0.076 1.341 (0.970–1.852) 0.075
c2=2.875; p=0.090
A 151 0.243 119 0.207 0.746 (0.540–1.031) 0.076 0.746 (0.540–1.030) 0.075
G 471 0.757 457 0.793 1.340 (0.970–1.852) 0.076 1.341 (0.970–1.852) 0.075
c.2285T>C – PARP1 (rs1136410)
A/A 201 0.646 191 0.663 1.078 (0.769–1.510) 0.664 1.074 (0.767–1.509) 0.670
A/G 103 0.331 82 0.285 0.804 (0.567–1.139) 0.219 0.804 (0.567–1.141) 0.222
G/G 7 0.023 15 0.052 2.384 (0.959–5.939) 0.062 2.385 (0.958–5.936) 0.062
c2=4.672; p=0.097
A 505 0.812 462 0.806 0.960 (0.720–1.280) 0.780 0.959 (0.718–1.279) 0.774
G 117 0.188 112 0.194 1.042 (0.781–1.389) 0.780 1.043 (0.782–1.392) 0.774
c.580C>T – XRCC1 (rs1799782)
GG 274 0.881 244 0.847 0.749 (0.468–1.198) 0.228 0.749 (0.467–1.201) 0.231
GA 36 0.116 42 0.146 1.304 (0.809–2.102) 0.275 1.303 (0.807–2.104) 0.279
AA 1 0.003 2 0.007 2.168 (0.196–24.036) 0.528 2.161 (0.191–23.970) 0.530
c2=1.652; p=0.438
G 584 0.939 530 0.920 0.750 (0.480–1.171) 0.206 0.750 (0.479–1.174) 0.208
A 38 0.061 46 0.080 1.334 (0.854–2.084) 0.206 1.33 (0.852–2.087) 0.208
c.1196A>G – XRCC1 (rs25487)
C/C 130 0.418 108 0.375 0.835 (0.602–1.160) 0.283 0.834 (0.600–1.158) 0.279
C/T 138 0.444 145 0.503 1.271 (0.922–1.753) 0.144 1.272 (0.922–1.755) 0.142
T/T 43 0.138 35 0.122 0.862 (0.535–1.391) 0.543 0.863 (0.535–1.392) 0.546
c2=2.147; p=0.342
C 398 0.640 361 0.627 0.944 (0.745–1.197) 0.634 0.943 (0.744–1.196) 0.629
T 224 0.360 215 0.373 1.059 (0.835–1.343) 0.634 1.060 (0.836–1.345) 0.629
c.*83A>C – LIG3 (rs4796030)
A/A 31 0.100 53 0.184 2.037 (1.266–3.279) 0.003 2.042 (1.268–3.288) 0.003
A/C 135 0.434 120 0.417 0.931 (0.673–1.288) 0.667 0.932 (0.674–1.289) 0.670
C/C 145 0.466 115 0.399 0.761 (0.550–1.053) 0.099 0.759 (0.548–1.051) 0.097
c2=9.236; p=0.010
A 197 0.317 226 0.392 1.366 (1.083–1.723) 0.008 1.369 (1.085–1.728) 0.008
C 425 0.683 350 0.608 0.732 (0.580–0.923) 0.008 0.730 (0.579–0.921) 0.008
Table 1.  Distribution of genotypes and alleles of the studied single-nucleotide polymorphism and the risk of recurrent depression 
disorder.
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Table 1 continued.  Distribution of genotypes and alleles of the studied single-nucleotide polymorphism and the risk of recurrent 
depression disorder.
Genotype
/Allele
Control
(n=311)
Depression
(n=288) Crude OR 
(95% CI)
p
Adjusted OR
(95% CI)*
p
Number Frequency Number Frequency
c.*50C>T – LIG3 (rs1052536)
CC 56 0.180 79 0.274 1.721 (1.168–2.538) 0.006 1.721 (1.167–2.537) 0.006
CT 166 0.534 136 0.472 0.782 (0.567–1.078) 0.133 0.781 (0.566–1.077) 0.131
TT 89 0.286 73 0.253 0.847 (0.590–1.216) 0.368 0.848 (0.590–1.218) 0.371
c2=7.607; p=0.022
C 278 0.447 294 0.510 1.295 (1.029–1.630) 0.028 1.295 (1.029–1.629) 0.028
T 344 0.553 282 0.490 0.772 (0.614–0.972) 0.028 0.772 (0.614–0.972) 0.028
c.-7C>T – LIG1 (rs20579)
A/A 3 0.010 7 0.024 2.558 (0.655–9.986) 0.177 2.566 (0.657–10.026) 0.175
A/G 73 0.235 65 0.226 0.950 (0.649–1.391) 0.793 0.950 (0.649–1.390) 0.792
G/G 235 0.756 216 0.750 0.970 (0.669–1.407) 0.873 0.970 (0.669–1.407) 0.874
c2=1.984; p=0.371
A 79 0.127 79 0.137 1.093 (0.781–1.530) 0.603 1.093 (0.781–1.530) 0.603
G 543 0.873 497 0.863 0.915 (0.654–1.280) 0.603 0.915 (0.654–1.280) 0.603
c.-468T>G – APEX1 (rs1760944)
T/T 56 0.180 48 0.167 0.911 (0.596–1.392) 0.665 0.910 (0.596–1.391) 0.664
T/G 142 0.457 157 0.545 1.445 (1.047–1.994) 0.025 1.444 (1.047–1.993) 0.025
G/G 113 0.363 83 0.288 0.709 (0.503–1.001) 0.051 0.710 (0.503–1.002) 0.051
c2=5.084; p=0.079
T 254 0.408 253 0.439 1.146 (0.908–1.445) 0.251 1.145 (0.908–1.445) 0.253
G 368 0.592 323 0.561 0.885 (0.702–1.116) 0.302 0.885 (0.702–1.117) 0.304
c.444T>G – APEX1 (rs1130409)
G/G 71 0.228 64 0.222 0.966 (0.658–1.418) 0.859 0.967 (0.658–1.419) 0.862
G/T 164 0.527 150 0.521 0.974 (0.707–1.343) 0.874 0.974 (0.706–1.342) 0.870
T/T 76 0.244 74 0.257 1.069 (0.739–1.548) 0.723 1.069 (0.739–1.548) 0.722
c2=0.131; p=0.937
G 306 0.492 278 0.483 0.962 (0.762–1.213) 0.741 0.962 (0.762–1.214) 0.743
T 316 0.508 298 0.517 1.040 (0.824–1.312) 0.741 1.040 (0.824–1.312) 0.743
* OR adjusted for sex. p<0.050 along with corresponding ORs are in bold; p<0.012 along with corresponding ORs are in bold 
and italic.
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Genotype
/Allele
Control
(n=298)
Early onset 
depression
(n=130)
Crude OR
(95% CI)
p
Adjusted OR* 
(95% CI)
p
Late onset 
depression
(n=128)
Crude OR
(95% CI)
p
Adjusted OR* 
(95% CI)
p
N (Freq.) N (Freq.) N (Freq.)
c.-441G>A – FEN1 (rs174538)
A/A 0 (–) 0 (–) – – – – 0 (–) – – – –
A/G 151 (0.49) 59 (0.45) 0.88 (0.58–1.33) 0.544 0.88 (0.58–1.33) 0.549 50 (0.39) 0.68 (0.45–1.03) 0.070 0.68 (0.45–1.04) 0.073
G/G 160 (0.51) 71 (0.55) 1.14 (0.75–1.71) 0.544 1.13 (0.75–1.71) 0.549 78 (0.61) 1.47 (0.97–2.24) 0.070 1.47 (0.96–2.23) 0.073
c2=0.253; p=0.615 c2=2.919; p=0.088
A 151 (0.24) 59 (0.23) 0.88 (0.58–1.33) 0.544 0.88 (0.58–1.33) 0.549 50 (0.19) 0.68 (0.45–1.03) 0.070 0.68 (0.45–1.04) 0.073
G 471 (0.76) 201 (0.77) 1.14 (0.75–1.71) 0.544 1.13 (0.75–1.71) 0.549 206 (0.81) 1.47 (0.97–2.24) 0.070 1.47 (0.96–2.23) 0.073
c.2285T>C – PARP1 (rs1136410)
A/A 201 (0.65) 85 (0.65) 1.03 (0.67–1.59) 0.880 1.03 (0.67–1.58) 0.898 86 (0.67) 1.12 (0.72–1.73) 0.609 1.13 (0.73–1.75) 0.590
A/G 103 (0.33) 39 (0.30) 0.86 (0.56–1.35) 0.523 0.87 (0.56–1.36) 0.542 35 (0.27) 0.76 (0.48–1.12) 0.237 0.75 (0.48–1.19) 0.219
G/G 7 (0.02) 6 (0.05) 2.10 (0.69–6.38) 0.190 2.08 (0.68–6.31) 0.197 7 (0.06) 2.51 (0.86–7.31) 0.091 2.60 (0.89–7.60) 0.081
c2=2.024; p=0.364 c2=3.997; p=0.136
A 505 (0.81) 209 (0.80) 0.95 (0.65–1.38) 0.776 0.94 (0.65–1.37) 0.766 207 (0.81) 0.98 (0.67–1.42) 0.908 0.98 (0.67–1.43) 0.914
G 117 (0.19 51 (0.20) 1.06 (0.73–1.54) 0.776 1.06 (0.73–1.54) 0.766 49 (0.19) 1.02 (0.70–1.49) 0.908 1.02 (0.70–1.49) 0.914
c.580C>T – XRCC1 (rs1799782)
G/G 274 (0.88) 108 (0.83) 0.66 (0.37–1.18) 0.159 0.67 (0.38–1.19) 0.174 110 (0.86) 0.83 (0.45–1.51) 0.534 0.79 (0.43–1.46) 0.459
G/A 36 (0.12) 21 (0.16) 1.47 (0.82–2.63) 0.193 1.45 (0.81–2.61) 0.210 17 (0.13) 1.17 (063–2.17) 0.618 1.21 (0.65–2.26) 0.547
A/A 1 (0.00) 1 (0.01) 2.40 (0.15–38.7) 0.536 2.41 (0.15–38.9) 0.535 1 (0.01) 2.44 (0.15–39.3) 0.529 2.71 (0.17–43.9) 0.484
c2=2.159; p=0.334 c2=0.688; p=0.709
G 584 (0.94) 237 (0.91) 0.67 (0.39–1.15) 0.146 0.68 (0.39–1.17) 0.159 237 (0.93) 0.81 (0.46–1.44) 0.475 0.78 (0.44–1.39) 0.400
A 38 (0.06) 23 (0.09) 1.49 (0.87–2.57) 0.146 1.48 (0.86–2.55) 0.159 19 (0.07) 1.23 (0.70–2.18) 0.475 1.28 (0.72–2.28) 0.400
c.1196A>G – XRCC1 (rs25487)
C/C 130 (0.42) 52 (0.40) 0.93 (0.61–1.41) 0.736 0.92 (0.61–1.40) 0.706 50 (0.39) 0.89 (0.59–1.36) 0.596 0.91 (0.59–1.38) 0.642
C/T 138 (0.44) 65 (0.50) 1.25 (0.83–1.89) 0.208 1.26 (0.84–1.90) 0.268 60 (0.47) 1.11 (0.73–1.67) 0.632 1.10 (0.73–1.66) 0.654
T/T 43 (0.14) 13 (0.10) 0.69 (0.36–1.34) 0.273 0.69 (0.36–1.34) 0.273 18 (0.14) 1.02 (0.56–1.85) 0.948 1.01 (0.55–1.82) 0.987
c2=1.760; p=0.415 c2=0.295; p=0.863
C 398 (0.64) 169 (0.65) 1.05 (0.77–1.42) 0.774 1.04 (0.77–1.41) 0.789 160 (0.63) 0.94 (0.70–1.27) 0.681 0.95 (0.70–1.28) 0.734
T 224 (0.36) 91 (0.35) 0.96 (0.71–1.30) 0.774 0.96 (0.71–1.30) 0.789 96 (0.37) 1.06 (0.79–1.43) 0.681 1.05 (0.78–1.42) 0.734
c.*83A>C – LIG3 (rs4796030)
A/A 31 (0.10) 28 (0.21) 2.48 (1.42–4.34) 0.001 2.48 (1.42–4.34) 0.001 24 (0.19) 2.08 (1.17–3.72) 0.013 2.06 (1.15–3.67) 0.015
A/C 135 (0.43) 58 (0.45) 1.05 (0.69–1.59) 0.816 1.06 (0.70–1.60) 0.792 46 (0.36) 0.73 (0.48–1.12) 0.149 0.73 (0.47–1.11) 0.141
C/C 145 (0.47) 44 (0.34) 0.59 (0.38–0.90) 0.014 0.58 (0.38–0.89) 0.013 58 (0.45) 0.95 (0.63–1.43) 0.802 0.96 (0.64–1.46) 0.851
c2=12.697; p=0.002 c2=6.844; p=0.033
A 197 (0.32) 114 (0.44) 1.66 (1.23–2.23) <0.001 1.67 (1.24–2.24) <0.001 94 (0.37) 1.23 (0.92–1.66) 0.164 1.22 (0.91–1.65) 0.184
C 425 (0.68) 146 (0.56) 0.60 (0.45–0.81) <0.001 0.60 (0.45–0.81) <0.001 162 (0.63) 0.81 (0.60–1.09) 0.164 0.82 (0.61–1.10) 0.184
Table 2.  Distribution of genotypes and alleles of the studied single-nucleotide polymorphism and the age of recurrent depression 
disorder onset.
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Table 2 continued.  Distribution of genotypes and alleles of the studied single-nucleotide polymorphism and the age of recurrent 
depression disorder onset.
Genotype
/Allele
Control
(n=298)
Early onset 
depression
(n=130)
Crude OR
(95% CI)
p
Adjusted OR* 
(95% CI)
p
Late onset 
depression
(n=128)
Crude OR
(95% CI)
p
Adjusted OR* 
(95% CI)
p
N (Freq.) N (Freq.) N (Freq.)
c.*50C>T – LIG3 (rs1052536)
C/C 56 (0.18) 40 (0.31) 2.02 (1.26–3.24) 0.003 2.02 (1.26–3.24) 0.003 32 (0.25) 1.52 (0.93–2.49) 0.098 1.53 (0.93–2.50) 0.094
C/T 166 (0.53) 64 (0.49) 0.85 (0.56–1.28) 0.427 0.84 (0.56–1.27) 0.408 58 (0.55) 0.72 (0.48–1.09) 0.125 0.73 (0.48–1.10) 0.133
T/T 89 (0.29) 26 (0.20) 0.62 (0.38–1.02) 0.062 0.63 (0.38–1.03) 0.066 38 (0.30) 1.05 (0.67–1.66) 0.822 1.04 (0.66–1.64) 0.863
c2=9.773; p=0.008 c2=3.404; p=0.182
C 278 (0.45) 144 (0.55) 1.58 (1.16–2.13) 0.003 1.57 (1.16–2.13) 0.003 122 (0.48) 1.13 (0.84–1.52) 0.417 1.14 (0.85–1.53) 0.392
T 344 (0.55) 116 (0.45) 0.64 (0.47–0.86) 0.003 0.64 (0.47–0.86) 0.003 134 (0.52) 0.88 (0.66–1.19) 0.417 0.88 (0.65–1.18) 0.392
c.-7C>T – LIG1 (rs20579)
A/A 3 (0.01) 3 (0.02) 2.43 (0.48–12.2) 0.282 2.43 (0.48–12.2) 0.281 4 (0.03) 3.31 (0.73–15.0) 0.120 3.20 (0.70–14.6) 0.132
A/G 73 (0.23) 25 (0.19) 0.78 (0.47–1.29) 0.329 0.78 (0.47–1.29) 0.328 32 (0.25) 1.09 (0.67–1.75) 0.733 1.09 (0.68–1.76) 0.718
G/G 235 (0.76) 102 (0.79) 1.18 (0.72–1.93) 0.513 1.18 (0.72–1.93) 0.512 92 (0.72) 0.83 (0.52–1.32) 0.421 0.83 (0.52–1.31) 0.417
c2=2.059; p=0.357 c2=2.908; p=0.234
A 79 (0.13) 31 (0.12) 0.93 (0.59–1.45) 0.748 0.93 (0.59–1.45) 0.747 40 (0.16) 1.28 (0.84–1.94) 0.246 1.28 (0.84–1.94) 0.249
G 543 (0.87) 229 (0.88) 1.08 (0.69–1.68) 0.748 1.08 (0.69–1.68) 0.747 216 (0.84) 0.78 (0.52–1.19) 0.246 0.78 (0.52–1.19) 0.249
c.-468T>G – APEX1 (rs1760944)
T/T 56 (0.18) 16 (0.12) 0.64 (0.35–1.16) 0.142 0.64 (0.35–1.16) 0.137 29 (0.23) 1.33 (0.81–2.21) 0.263 1.34 (0.81–2.23) 0.254
T/G 142 (0.46) 73 (0.56) 1.52 (1.01–2.30) 0.045 1.52 (1.01–2.29) 0.047 66 (0.52) 1.27 (0.84–1.91) 0.261 1.27 (0.84–1.92) 0.253
G/G 113 (0.36) 41 (0.32) 0.81 (0.52–1.25) 0.336 0.81 (0.53–1.26) 0.353 33 (0.26) 0.61 (0.39–0.96) 0.034 0.60 (0.38–0.95) 0.031
c2=2.908; p=0.234 c2=4.716; p=0.095
T 254 (0.41) 105 (0.40) 0.98 (0.73–1.32) 0.900 0.98 (0.73–1.31) 0.872 124 (0.48) 1.35 (1.01–1.80) 0.043 1.36 (1.01–1.82) 0.039
G 368 (0.59) 155 (0.60) 1.02 (0.76–1.37) 0.900 1.03 (0.76–1.38) 0.872 132 (0.52 0.74 (0.56–0.99) 0.043 0.74 (0.55–0.98) 0.039
c.444T>G – APEX1 (rs1130409)
G/G 71 (0.23) 27 (0.21) 0.89 (0.54–1.46) 0.635 0.89 (0.54–1.48) 0.664 33 (0.26) 1.17 (0.73–1.89) 0.509 1.17 (0.73–1.89) 0.517
G/T 164 (0.53) 68 (0.52) 0.98 (0.65–1.48) 0.935 0.98 (0.65–1.47) 0.914 66 (0.51) 0.95 (0.63–1.44) 0.823 0.96 (0.64–1.45) 0.844
T/T 76 (0.24) 35 (0.27) 1.14 (0.72–1.82) 0.584 1.14 (0.71–1.81) 0.590 29 (0.23) 0.91 (0.55–1.48) 0.691 0.90 (0.55–1.47) 0.677
c2=0.403; p=0.817 c2=0.477; p=0.788
G 306 (0.49) 122 (0.47) 0.91 (0.67–1.22) 0.527 0.91 (0.68–1.23) 0.547 132 (0.52) 1.11 (0.82–1.49) 0.514 1.11 (0.82–1.49) 0.512
T 316 (0.51) 138 (0.53) 1.10 (0.82–1.48) 0.527 1.10 (0.81–1.48) 0.547 124 (0.48) 0.91 (0.67–1.22) 0.514 0.91 (0.67–1.22) 0.512
Early onset depression – the first episode occurred at or before 35 years of age. Late onset depression – the first episode oc-
curred after 35 years of age. * OR adjusted for sex. p<0.050 along with corresponding ORs are in bold; p<0.012 along with cor-
responding ORs are in bold and italic.
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Combined 
genotype
Control (n=311) Depression (n=288) Crude OR 
(95% CI)
p
Adjusted OR* 
(95% CI)
p
Number Frequency Number Frequency
c.444T>G – APEX1 (rs1130409) and c.1196A>G – XRCC1 (rs25487)
G/T-C/C 75 0.241 48 0.167 0.629 (0.420–0.943) 0.025 0.627 (0.418–0.940) 0.024
G/T-C/T 68 0.219 88 0.306 1.572 (1.089–2.271) 0.016 1.573 (1.089–2.272) 0.016
c.-468T>G – APEX1 (rs1760944) and c.*50C>T – LIG3 (rs1052536)
G/G-C/T 66 0.212 37 0.128 0.547 (0.353–0.849) 0.007 0.547 (0.353–0.850) 0.007
c.-468T>G – APEX1 (rs1760944) and c.*83A>C – LIG3 (rs4796030)0
G/G-A/C 53 0.170 28 0.097 0.524 (0.321–0.855) 0.010 0.524 (0.321–0.856) 0.010
c.-468T>G – APEX1 (rs1760944) and c.580C>T – XRCC1 (rs1799782)
G/G-G/G 99 0.318 69 0.240 0.675 (0.470–0.968) 0.033 0.675 (0.470–0.969) 0.033
c.-468T>G – APEX1 (rs1760944) and c.1196A>G – XRCC1 (rs25487)
T/G-C/T 62 0.199 80 0.278 1.545 (1.057–2.257) 0.025 1.546 (1.058–2.260) 0.024
c.-468T>G – APEX1 (rs1760944) and c.-441G>A – FEN1 (rs174538)
T/G-G/G 75 0.241 93 0.323 1.501 (1.049–2.148) 0.026 1.500 (1.048–2.148) 0.027
G/G-A/G 55 0.177 32 0.111 0.582 (0.364–0.930) 0.024 0.582 (0.364–0.931) 0.024
c.-7C>T – LIG1 (rs20579) and c.*50C>T – LIG3 (rs1052536)
G/G-C/C 44 0.141 59 0.205 1.563 (1.019–2.400) 0.041 1.564 (1.019–2.400) 0.041
c.-7C>T – LIG1 (rs20579) and c.*83A>C – LIG3 (rs4796030)
G/G-A/A 25 0.080 40 0.139 1.845 (1.088–3.128) 0.023 1.851 (1.091–3.139) 0.022
c.-7C>T – LIG1 (rs20579) and c.-441G>A – FEN1 (rs174538)
A/G-A/G 37 0.119 19 0.066 0.523 (0.293–0.933) 0.028 0.523 (0.293–0.932) 0.028
c.*50C>T – LIG3 (rs1052536) and c.580C>T – XRCC1 (rs1799782)
C/C-G/G 47 0.151 63 0.219 1.573 (1.036–2.388) 0.034 1.572 (1.036–2.387) 0.034
c.*50C>T – LIG3 (rs1052536) and c.2285T>C – PARP1 (rs1136410)
C/C-A/A 39 0.125 57 0.198 1.721 (1.105–2.681) 0.016 1.720 (1.104–2.681) 0.017
c.*50C>T – LIG3 (rs1052536) and c.-441G>A – FEN1 (rs174538)
C/C-G/G 27 0.087 48 0.167 2.104 (1.274–3.475) 0.004 2.104 (1.274–3.475) 0.004
C/T-A/G 86 0.277 58 0.201 0.660 (0.451–0.965) 0.032 0.658 (0.449–0.963) 0.031
c.*83A>C – LIG3 (rs4796030) and c.580C>T – XRCC1 (rs1799782)
A/A-G/G 25 0.080 43 0.149 2.008 (1.192–3.383) 0.009 2.015 (1.195–3.398) 0.009
c.*83A>C – LIG3 (rs4796030) and c.1196A>G – XRCC1 (rs25487)
A/A-C/T 13 0.042 27 0.094 2.371 (1.199–4.691) 0.013 2.374 (1.200–4.698) 0.013
c.*83A>C – LIG3 (rs4796030) and c.2285T>C – PARP1 (rs1136410)
A/A-A/A 19 0.061 37 0.128 2.265 (1.271–4.039) 0.006 2.268 (1.272–4.044) 0.006
C/C-A/G 54 0.174 31 0.108 0.574 (0.357–0.922) 0.022 0.574 (0.357–0.922) 0.022
c.*83A>C – LIG3 (rs4796030) and c.-441G>A – FEN1 (rs174538)
A/A-G/G 13 0.042 35 0.122 3.171 (1.642–6.125) < 0.001 3.171 (1.642–6.124) <0.001
c.580C>T – XRCC1 (rs1799782) and c.-441G>A – FEN1 (rs174538)
G/G-A/G 135 0.434 101 0.351 0.704 (0.506–0.979) 0.037 0.704 (0.506–0.979) 0.037
c.1196A>G – XRCC1 (rs25487) and c.2285T>C – PARP1 (rs1136410)
C/T-G/G 3 0.010 10 0.035 3.693 (1.006–13.556) 0.049 3.691 (1.006–13.549) 0.049
c.2285T>C – PARP1 (rs1136410) and c.-441G>A – FEN1 (rs174538)
G/G-G/G 3 0.010 10 0.035 3.693 (1.006–13.556) 0.049 3.699 (1.007–13.578) 0.049
Table 3. Gene-gene interactions of the studied polymorphisms and the risk of rDD.
* OR adjusted for sex. p<0.05 along with corresponding ORs are in bold; p<0.012 along with corresponding ORs are in bold and italic.
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Gene-gene interactions and the risk of recurrent 
depression disorder
Additionally, we evaluated whether the gene-gene combina-
tions can modulate the risk of depression. The results of this 
analysis are shown in Table 3 which presents only statistically 
significant results, and Supplementary Table 1 which presents 
all results. We found several significant associations, some of 
which were for genes that alone did not modulate rDD risk. 
Combined genotype G/T-C/C of the c.444T>G – APEX1 and the 
c.1196A>G – XRCC1 was positively correlated with rDD, while 
the combined genotype G/T-C/T negatively correlated with 
rDD. Additionally, the combined genotype A/G-A/G of the c.-
7C>T – LIG1 and the c.-441G>A – FEN1 was associated with a 
decreased risk of depression.
Haplotypes of the studied single-nucleotide polymorphism 
and the risk of recurrent depression disorder
The distribution of haplotypes of the studied SNPs are pre-
sented in Table 4 and Supplementary Table 2. We only found 
statistically significant results for the haplotypes of c.*50C>T 
– LIG3 and c.*83A>C – LIG3 – haplotype CA, which were asso-
ciated with an increased rDD risk, while haplotype TC was as-
sociated with a decreased rDD risk.
Discussion
As indicated in the introduction, depression is accompanied 
by inflammation and increased oxidative stress, both of which 
may be important in its pathogenesis [2]. Oxidative stress may 
induce DNA damage, and our team and others have found in-
creased levels of oxidatively modified DNA bases, especially 
8-oxoG, DNA breaks, and an alkali labile site in depressed pa-
tients [8–13,15]. This kind of DNA damage is mainly repaired 
by the BER. PBMCs isolated from cells of rDD patients repaired 
hydrogen peroxide-induced oxidative DNA damage less effi-
ciently than from the cells of controls, which may indicate 
impairments in this repair pathway [15]. Furthermore, recent 
studies have shown that some polymorphic variants of the 
BER genes may negatively impact the repair of oxidative DNA 
damage, and our team found that glycosylase SNPs can mod-
ulate rDD risk [17,23,24]. Therefore, in this study, nine SNPs of 
the six genes encoding proteins involved in later steps of BER 
were genotyped; and to our knowledge, none of them have 
been studied in the context of mental illnesses.
One of the selected genes was LIG3, which encodes ligase, an 
essential component of BER, sealing in place the new base in 
the final step of this pathway [25,26]. It is mainly utilized in 
short-patch BER, but it can be used as a “back-up” ligase in the 
long-patch sub-pathway [27]. LIG3 also plays a major role in 
mitochondrial BER (mtBER), since its depletion by siRNA leads 
to the reduction of mitochondrial DNA (mtDNA) copy number 
and elevations in DNA single-strand breaks [28,29]. We exam-
ined the c.*50C>T and the c.*83A>C, both localized in UTR-3, 
where they can alter gene expression by affecting mRNA stabil-
ity, half-life, and degradation [30]. Indeed, the c.*83A>C affects 
the binding site of microRNA, modulating the risk of bladder 
cancer, whilst the c.*50C>T modulates the risk of young-onset 
lung cancer [31,32]. Here, both SNPs showed a significant as-
sociation with rDD (Table 1). We found that the AA genotype 
of the c.*83A>C and the CC genotype of c.*50C>T increased 
the risk of depression, with these genotypes also increasing 
cancer risk [31,32]. These SNPs are also associated with rDD 
onset with the c.*50C>T variant modifying the risk of early on-
set rDD only, with the c.*83A>C variant also being more asso-
ciated with early rather than late onset depression (Table 2). 
Such data indicates that these SNPs are linked to early inci-
dence of rDD, possibly being less related to non-genetic fac-
tors, which may have a greater role in late-life depression. 
Finally, we found that the haplotype C/A of the c.*50C>T and 
the c.*83A>C were associated with a significantly increased 
rDD risk, in contrast to the haplotype T/C, which was associ-
ated with decreased risk (Table 4).
Haplotypes
Control (n=311) Depression (n=288)
Crude OR (95% CI) p
Number Frequency Number Frequency
c.*50C>T – LIG3 (rs1052536) and c.*83A>C – LIG3 (rs4796030)
CA 264 0.212 350 0.304 1.620 (1.346–1.949) <0.001
CC 292 0.235 238 0.207 0.849 (0.699–1.030) 0.098
TA 130 0.105 102 0.089 0.832 (0.634–1.093) 0.187
TC 558 0.449 462 0.401 0.818 (0.696–0.963) 0.016
Table 4. Distribution of haplotypes of in the studied SNPs.
p<0.05 along with corresponding ORs are in bold.
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The next gene studied was APEX1. APEX1 encodes endonucle-
ase, which recognizes the apurinic/apyrimidinic (AP) site aris-
ing from the actions of glycosylases after the first BER step, 
but is also responsible for RNA processing and the regulation 
of transcription [33,34]. This protein takes part in mtBER, al-
though its role is still the subject of investigation. On the one 
hand, overexpression of mitochondrial APEX1 in human um-
bilical vein endothelial cells decreases apoptosis after H2O2-
induced oxidative stress, probably by enhancing mitochondrial 
DNA repair. However, on the other hand, expression of exonu-
clease III (with which APEX1 has significant homology) in the 
mitochondria of a malignant breast epithelial cell line caused 
cells to be more sensitive to oxidative stress due to deficient 
mtDNA repair [35,36]. We genotyped two polymorphisms in 
this gene: the c.-468T>G and the c.444T>G. The latter, located 
near the 5’ end of the gene, was found to affect the promot-
er strength and by this may modulate the risk of lung can-
cer [37,38]. The former causes amino acid substitution of as-
paragine to glutamic acid in codon 148 and although it did 
not alter the in vitro activity of APEX1, it modulated the risk 
of cancer and was associated with Parkinson’s disease, prob-
ably by affecting interactions of the enzyme with other BER 
proteins [39–42]. Data in our study showed that the hetero-
zygote of the c.-468T>G increased rDD risk (Table 1). This SNP 
was more associated with late onset rather than with early on-
set depression, which could mean that the c.-468T>G has low-
er penetration than the LIG3 polymorphisms and needs other 
factors to induce rDD later in life (Table 2). Although the het-
erozygote increased the risk only of early onset depression, 
the A allele homozygote and the A allele alone decreased late 
onset rDD risk, while the T allele increased this risk. These re-
sults are consistent with the work of Lo and colleagues that 
showed that the G allele increased luciferase reported gene 
expression in several adenocarcinoma cell lines [38]. The hy-
pothesis that this polymorphism had less impact on depres-
sion occurrence was confirmed by the fact that, only togeth-
er with heterozygotes of LIG3 SNPs genotype GG, was the risk 
for the disease decreased (Table 3). In the case of c.444T>G 
as well as haplotypes of these two APEX1 polymorphisms, we 
did not find any statistically significant results (Tables 1, 4).
Two SNPs were also genotyped in XRCC1, which encodes a pro-
tein that is not only an important component of BER, but also 
a component of other DNA repair pathways, such as single-
strand break repair and non-homologous end joining [43,44]. 
In BER, XRCC1 is involved in each of these pathway steps due 
to its function as a scaffold protein, which physically associates 
with repair enzymes [45]. Its polymorphisms are associated with 
cancers and neurodegenerative diseases such as Alzheimer’s 
disease [46–48]. Again two SNPs were genotyped: the c.580C>T, 
which is localized in a region that coordinates protein inte-
grations, whereas the c.1196A>G is positioned in the breast 
cancer 1 C terminus (BRCT1) domain, which is responsible for 
interactions with PARP [48–50]. No significant associations of 
depression with either genotypes, alleles, nor haplotypes of 
XRCC1 SNPs were found (Tables 1, 2, and Supplementary Table 
1). However, combined genotypes of this gene with genes en-
coding proteins interacting with XRCC1 provided some statis-
tically significant results. The most interesting being the com-
bination of the c.1196A>G – XRCC1 and the c.444T>G – APEX1, 
which alone were not rDD associated. In this gene-gene inter-
action, the latter SNP is more important due to changes of this 
polymorphism’s genotype causing either a decrease (homo-
zygote CC) or an increase (heterozygote) in rDD risk (Table 3). 
Moreover, this heterozygote increased the risk of rDD in com-
bination with the TG genotype of the c.-468T>G – APEX1 and 
AA genotype of the c.*83A>C – LIG3. Such results suggest that 
this SNP may have little if any impact on the development of 
depression. Similarly, the two polymorphisms of FEN1 and LIG1, 
although neither alone influenced rDD risk, the combined gen-
otype consisting of heterozygotes decreased rDD risk (Tables 
1, 3). FEN1 encodes structure specific endonuclease that re-
moves the 5’-flap structures arising during long-patch BER and 
is involved in maturation of Okazaki fragments, as well as re-
leasing stalled replication forks [51–53]. It also participates in 
maintaining the mitochondrial genome [54]. A polymorphism 
of this gene, the c.-441G>A, reduced expression of FEN1, ele-
vated levels of DNA damage, and increased risk of lung can-
cer in individuals carrying the GG genotype [55]. In our study, 
this SNP was associated with depression in combination with 
other SNPs, most notably the combination of its GG genotype 
with the homozygote AA of the c.*83A>C – LIG3 or the homo-
zygote CC of the c.*50C>T – LIG3 significantly increased rDD 
risk (Table 4). The product of LIG1 is also involved in long-patch 
BER and maturation of Okazaki fragments [56]. The SNP lo-
cated in the 5’-UTR of this gene is associated with lung can-
cer in heterozygote carriers, although its influence on gene ex-
pression is unknown [32]. We found that its heterozygote in 
combination with the homozygote AA of the c.*83A>C – LIG3 
or the homozygote CC of the c.*50C>T – LIG3 was correlated 
with rDD (Table 4). It must be noted that this association was 
weaker than in the case of the c.-441G>A – FEN1, which could 
indicate that the latter SNP is more involved in the pathogen-
esis of rDD than the former. Finally, we genotyped one SNP in 
PARP1, which encodes protein involved not only in DNA dam-
age, including the BER, but also in the inflammation response, 
transcription, and apoptosis [57,58]. This SNP was found to re-
duce enzyme activity by about 40% [59]. However, no signifi-
cant correlation was found between this polymorphisms and 
depression (Tables 1, 2).
The results showing a strong association between depres-
sion and some polymorphism variants of LIG3, their haplo-
types, or their interactions with other SNPs of BER genes are 
especially interesting in the context of recent work demon-
strating impairments in oxidative DNA damage repair in rDD 
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patients [15]. DNA damage repair kinetics in the aforemen-
tioned study revealed that the differences between controls 
and cases were more likely to be present in the later stages of 
BER, as initial DNA damage caused by the actions of DNA gly-
cosylases in both groups occurred at the same time. As such, 
it can be speculated that this difference may arise, at least 
partly, by the more frequent occurrence of a specific variant 
of LIG3 and others genes involved in the later steps of BER in 
depressed patients versus controls. Furthermore, as indicat-
ed earlier, LIG3 plays an important role in the maintenance of 
the mitochondrial genome and a growing number of reports 
indicate the importance of mitochondrial dysfunctions in de-
pression [28,29]. Depressed patients have lower mitochondrial 
ATP production, lower CoQ10 levels and increased mitochon-
drial ROS, all of which indicate mitochondrial damage [60–63]. 
The mitochondrial impairments may be due to increased mtD-
NA damage, and elevated levels of mtDNA deletions are found 
in depressed patients’ muscles and PBMCs [61,62]. Such dele-
tions can be triggered by DNA damage, and one of the most 
frequently occurring deletions, called “common deletion”, is 
triggered by a single-strand break following incomplete DNA 
damage repair, when ligase does not seal the nick in the last 
step of BER [64]. Given the classical decrease in serotonin in 
depression, and its role as a precursor for melatonin and a sig-
nificant regulator of mitochondrial functioning as well as an 
inhibitor of oxidative damage and inflammation, it is not un-
likely that variations in melatonin availability will interact with 
genes regulating the BER [65].
Our work has some limitations. One limitation was a relatively 
small sample size, although comparable studies concerning de-
pression had similar study group size [66,67]. In addition, our 
results cannot be generalized to the world population, due to 
ethnic homogeneity of the studied population.
Conclusions
This study is concordant with the extant literature in showing 
that SNPs of genes involved in oxidative DNA damage repair 
may modulate the risk of rDD [17]. Further studies are needed 
to elucidate the role of nuclear DNA as well as mitochondrial 
DNA damage and repair in pathogenesis of depression, and the 
effect on clinical outcome. Aging effects on telomerase, which 
can be offset by melatonin, would be expected to interact with 
the genetic susceptibility to rDD, driven partly by BER SNPs.
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Combined 
genotype
Control (n=311) Depression (n=288) Crude OR 
(95% CI)
p
Adjusted OR* 
(95% CI)
p
Number Frequency Number Frequency
c.444T>G – APEX1 (rs1130409) and c.-7C>T – LIG1 (rs20579)
G/G-A/A 0 - 1 0.003 – – – –
G/G-A/G 20 0.064 18 0.063 0.970 (0.502–1.873) 0.928 0.970 (0.502–1.873) 0.928
G/G-G/G 51 0.164 45 0.156 0.944 (0.610–1.462) 0.797 0.945 (0.610–1.464) 0.800
G/T-A/A 2 0.006 5 0.017 2.730 (0.525–14.181) 0.232 2.771 (0.531–14.459) 0.227
G/T-A/G 44 0.141 33 0.115 0.785 (0.485–1.273) 0.327 0.785 (0.484–1.272) 0.326
G/T-G/G 118 0.379 112 0.389 1.041 (0.749–1.447) 0.812 1.040 (0.748–1.446) 0.817
T/T-A/A 1 0.003 1 0.003 1.080 (0.067–17.349) 0.957 1.068 (0.066–17.231) 0.963
T/T-A/G 9 0.029 14 0.049 1.715 (0.730–4.024) 0.216 1.713 (0.730–4.021) 0.217
T/T-G/G 66 0.212 59 0.205 0.956 (0.645–1.419) 0.825 0.957 (0.645–1.420) 0.827
c.444T>G – APEX1 (rs1130409) and c.*50C>T – LIG3 (rs1052536)
G/G-C/C 13 0.042 16 0.056 1.348 (0.637–2.855) 0.435 1.348 (0.637–2.854) 0.435
G/G-C/T 35 0.113 26 0.090 0.783 (0.458–1.336) 0.369 0.783 (0.459–1.337) 0.370
G/G-T/T 23 0.074 22 0.076 1.036 (0.564–1.902) 0.910 1.037 (0.565–1.906) 0.906
G/T-C/C 30 0.096 40 0.139 1.511 (0.913–2.499) 0.108 1.510 (0.912–2.498) 0.109
G/T-C/T 91 0.293 76 0.264 0.867 (0.606–1.240) 0.434 0.866 (0.605–1.240) 0.433
G/T-T/T 43 0.138 34 0.118 0.834 (0.515–1.350) 0.461 0.834 (0.516–1.350) 0.461
T/T-C/C 13 0.042 23 0.080 1.990 (0.988–4.006) 0.054 1.994 (0.990–4.018) 0.053
Supplementary Table 1. Gene-gene interactions of the studied polymorphisms and the risk of rDD.
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Combined 
genotype
Control (n=311) Depression (n=288) Crude OR 
(95% CI)
p
Adjusted OR* 
(95% CI)
p
Number Frequency Number Frequency
T/T-C/T 40 0.129 34 0.118 0.907 (0.557–1.478) 0.695 0.905 (0.555–1.476) 0.690
T/T-T/T 23 0.074 17 0.059 0.785 (0.411–1.502) 0.466 0.786 (0.411–1.505) 0.468
c.444T>G – APEX1 (rs1130409) and c.*83A>C – LIG3 (rs4796030)
G/G-A/A 5 0.016 12 0.042 2.661 (0.926–7.649) 0.069 2.658 (0.924–7.642) 0.070
G/G-A/C 32 0.103 26 0.090 0.865 (0.502–1.491) 0.602 0.866 (0.503–1.494) 0.606
G/G-C/C 34 0.109 26 0.090 0.808 (0.472–1.384) 0.439 0.809 (0.472–1.385) 0.440
G/T-A/A 17 0.055 27 0.094 1.789 (0.953–3.357) 0.070 1.790 (0.954–3.358) 0.070
G/T-A/C 70 0.225 64 0.222 0.984 (0.670–1.445) 0.933 0.984 (0.670–1.447) 0.936
G/T-C/C 77 0.248 59 0.205 0.783 (0.533–1.151) 0.213 0.781 (0.531–1.148) 0.208
T/T-A/A 9 0.029 14 0.049 1.715 (0.730–4.024) 0.216 1.730 (0.735–4.072) 0.210
T/T-A/C 33 0.106 30 0.104 0.980 (0.581–1.652) 0.938 0.979 (0.580–1.651) 0.936
T/T-C/C 34 0.109 30 0.104 0.947 (0.564–1.593) 0.838 0.946 (0.563–1.591) 0.835
c.444T>G – APEX1 (rs1130409) and c.580C>T – XRCC1 (rs1799782)
G/G-G/G 62 0.199 51 0.177 0.864 (0.573–1.304) 0.784 0.865 (0.573–1.306) 0.491
G/G-G/A 9 0.029 13 0.045 1.586 (0.668–3.769) 0.296 1.583 (0.666–3.766) 0.299
G/G-A/A 0 – 0 – – – – –
G/T-G/G 142 0.457 130 0.451 0.979 (0.710–1.351) 0.898 0.979 (0.710–1.351) 0.899
G/T-G/A 22 0.071 19 0.066 0.928 (0.491–1.752) 0.817 0.925 (0.489–1.749) 0.810
G/T-A/A 0 – 1 0.003 – – – –
T/T-G/G 70 0.225 63 0.219 0.964 (0.655–1.418) 0.852 0.964 (0.656–1.419) 0.854
T/T-G/A 5 0.016 10 0.035 2.201 (0.743–6.520) 0.154 2.198 (0.742–6.512) 0.155
T/T-A/A 1 0.003 1 0.003 1.080 (0.067–17.349) 0.957 1.080 (0.067–17.354) 0.956
c.444T>G – APEX1 (rs1130409) and c.1196A>G – XRCC1 (rs25487)
G/G-C/C 28 0.090 30 0.104 1.175 (0.684–2.021) 0.559 1.177 (0.684–2.024) 0.556
G/G-C/T 36 0.116 27 0.094 0.790 (0.467–1.338) 0.381 0.791 (0.467–1.339) 0.382
G/G-T/T 7 0.023 7 0.024 1.082 (0.375–3.123) 0.884 1.082 (0.375–3.124) 0.884
G/T-C/C 75 0.241 48 0.167 0.629 (0.420–0.943) 0.025 0.627 (0.418–0.940) 0.024
G/T-C/T 68 0.219 88 0.306 1.572 (1.089–2.271) 0.016 1.573 (1.089–2.272) 0.016
G/T-T/T 21 0.068 14 0.049 0.706 (0.352–1.415) 0.326 0.706 (0.352–1.417) 0.328
T/T-C/C 27 0.087 30 0.104 1.223 (0.708–2.113) 0.470 1.222 (0.707–2.111) 0.472
T/T-C/T 34 0.109 30 0.104 0.947 (0.564–1.593) 0.838 0.948 (0.564–1.594 0.840
T/T-T/T 15 0.048 14 0.049 1.008 (0.478–2.127) 0.983 1.009 (0.478–2.129) 0.981
c.444T>G – APEX1 (rs1130409) and c.2285T>C – PARP1 (rs1136410)
G/G-A/A 44 0.141 48 0.167 1.214 (0.778–1.893) 0.393 1.214 (0.778–1.893) 0.393
G/G-A/G 25 0.080 16 0.056 0.673 (0.352–1.288) 0.232 0.674 (0.352–1.291) 0.234
G/G-G/G 2 0.006 0 – – – – –
G/T-A/A 104 0.334 96 0.33 0.995 (0.708–1.398) 0.978 0.993 (0.706–1.397) 0.967
G/T-A/G 57 0.183 46 0.160 0.847 (0.553–1.298) 0.446 0.848 (0.553–1.301) 0.450
G/T-G/G 3 0.010 8 0.028 2.933 (0.771–11.166) 0.115 2.938 (0.772–11.186) 0.114
T/T-A/A 53 0.170 47 0.163 0.949 (0.617–1.460) 0.813 0.950 (0.618–1.461) 0.816
T/T-A/G 21 0.068 20 0.069 1.031 (0.546–1.944) 0.926 1.029 (0.546–1.942) 0.929
T/T-G/G 2 0.006 7 0.024 3.849 (0.793–18.681) 0.094 3.845 (0.792–18.666) 0.095
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Combined 
genotype
Control (n=311) Depression (n=288) Crude OR 
(95% CI)
p
Adjusted OR* 
(95% CI)
p
Number Frequency Number Frequency
c.444T>G – APEX1 (rs1130409) and c.-441G>A – FEN1 (rs174538)
G/G-A/A 0 – 0 - – – – –
G/G-A/G 38 0.122 24 0.083 0.653 (0.381–1.119) 0.121 0.653 (0.381–1.119) 0.121
G/G-G/G 33 0.106 40 0.139 1.359 (0.831–2.222) 0.222 1.361 (0.832–2.226) 0.220
G/T-A/A 0 – 2 – – – – –
G/T-A/G 75 0.241 61 0.212 0.846 (0.576–1.241) 0.392 0.845 (0.575–1.240) 0.389
G/T-G/G 89 0.286 89 0.309 1.116 (0.786–1.584) 0.541 1.115 (0.785–1.584) 0.542
T/T-A/A 0 – 0 – – – – –
T/T-A/G 38 0.122 34 0.118 0.962 (0.587–1.575) 0.877 0.692 (0.587–1.575) 0.877
T/T-G/G 38 0.122 40 0.139 1.159 (0.720–1.865) 0.544 1.159 (0.720–1.865) 0.544
c.-468T>G – APEX1 (rs1760944) and c.-7C>T – LIG1 (rs20579)
T/T-A/A 1 0.003 1 0.003 1.080 (0.067–17.349) 0.957 1.080 (0.067–17.354) 0.956
T/T-A/G 11 0.035 11 0.038 1.083 (0.462–2.538) 0.854 1.086 (0.463–2.546) 0.850
T/T-G/G 44 0.141 36 0.125 0.867 (0.540–1.391) 0.554 0.865 (0.539–1.389) 0.550
T/G-A/A 2 0.006 4 0.014 2.176 (0.396–11.971) 0.371 2.187 (0.397–12.046) 0.369
T/G-A/G 32 0.103 33 0.115 1.128 (0.674–1.888) 0.646 1.128 (0.674–1.888) 0.647
T/G-G/G 108 0.347 120 0.417 1.343 (0.965–1.869) 0.081 0.856 (0.614–1.192) 0.356
G/G-A/A 0 - 2 0.007 – – – –
G/G-A/G 30 0.096 21 0.073 0.737 (0.412–1.319) 0.304 0.735 (0.411–1.317) 0.301
G/G-G/G 83 0.267 60 0.208 0.723 (0.495–1.057) 0.094 0.723 (0.494–1.058) 0.095
c.-468T>G – APEX1 (rs1760944) and c.*50C>T – LIG3 (rs1052536)
T/T-C/C 12 0.039 19 0.066 1.760 (0.839–3.693) 0.135 1.759 (0.838–3.691) 0.136
T/T-C/T 25 0.080 18 0.063 0.763 (0.407–1.430) 0.398 0.760 (0.405–1.426) 0.392
T/T-T/T 19 0.061 11 0.038 0.610 (0.285–1.306) 0.203 0.611 (0.285–1.310) 0.205
T/G-C/C 28 0.090 39 0.125 1.444 (0.857–2.434) 0.168 1.443 (0.855–2.433) 0.169
T/G-C/T 75 0.241 81 0.281 1.231 (0.854–1.774) 0.264 1.231 (0.854–1.774) 0.265
T/G-T/T 39 0.125 40 0.139 1.125 (0.701–1.806) 0.626 1.021 (0.636–1.639) 0.931
G/G-C/C 16 0.051 24 0.083 1.676 (0.872–3.224) 0.122 1.682 (0.874–3.237) 0.120
G/G-C/T 66 0.212 37 0.128 0.547 (0.353–0.849) 0.007 0.547 (0.353–0.850) 0.007
G/G-T/T 31 0.100 22 0.076 0.747 (0.422–1.323) 0.317 0.747 (0.422–1.324) 0.318
c.-468T>G – APEX1 (rs1760944) and c.*83A>C – LIG3 (rs4796030)0
T/T-A/A 4 0.013 10 0.035 2.761 (0.856–8.903) 0.089 2.768 (0.858–8.930) 0.088
T/T-A/C 18 0.058 18 0.063 1.085 (0.553–2.129) 0.812 1.083 (0.552–2.126) 0.816
T/T-C/C 34 0.109 20 0.069 0.608 (0.341–1.083) 0.091 0.608 (0.341–1.083) 0.091
T/G-A/A 17 0.055 24 0.083 1.572 (0.826–2.991) 0.168 1.572 (0.826–2.991) 0.168
T/G-A/C 64 0.206 74 0.257 1.335 (0.911–1.954) 0.138 1.335 (0.912–1.955) 0.138
T/G-C/C 61 0.196 59 0.205 1.056 (0.708–1.576) 0.790 1.054 (0.706–1.574) 0.796
G/G-A/A 10 0.032 19 0.066 2.126 (0.971–4.653) 0.059 2.134 (0.975–4.674) 0.058
G/G-A/C 53 0.170 28 0.097 0.524 (0.321–0.855) 0.010 0.524 (0.321–0.856) 0.010
G/G-C/C 50 0.161 36 0.125 0.746 (0.470–1.184) 0.213 0.745 (0.469–1.183) 0.212
c.-468T>G – APEX1 (rs1760944) and c.580C>T – XRCC1 (rs1799782)
T/T-G/G 45 0.145 41 0.142 0.981 (0.621–1.550) 0.935 0.982 (0.621–1.551) 0.937
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Combined 
genotype
Control (n=311) Depression (n=288) Crude OR 
(95% CI)
p
Adjusted OR* 
(95% CI)
p
Number Frequency Number Frequency
T/T-G/A 10 0.032 7 0.024 0.750 (0.282–1.997) 0.565 0.745 (0.279–1.989) 0.557
T/T-A/A 1 0.003 0 – – – – –
T/G-G/G 130 0.418 134 0.465 1.211 (0.877–1.674) 0.244 1.211 (0.877–1.673) 0.245
T/G-G/A 12 0.039 21 0.073 1.960 (0.946–4.059) 0.070 1.958 (0.945–4.058) 0.071
T/G-A/A 0 – 2 0.007 – – – –
G/G-G/G 99 0.318 69 0.240 0.675 (0.470–0.968) 0.033 0.675 (0.470–0.969) 0.033
G/G-G/A 14 0.045 14 0.049 1.084 (0.508–2.315) 0.835 1.082 (0.506–2.311) 0.840
G/G-A/A 0 – 0 – – – – –
c.-468T>G – APEX1 (rs1760944) and c.1196A>G – XRCC1 (rs25487)
T/T-C/C 27 0.087 19 0.066 0.743 (0.404–1.368) 0.340 0.741 (0.402–1.365) 0.336
T/T-C/T 25 0.080 23 0.080 0.993 (0.550–1.792) 0.981 0.993 (0.550–1.792) 0.982
T/T-T/T 4 0.013 6 0.021 1.633 (0.456–5.847) 0.451 1.638 (0.457–5.868) 0.448
T/G-C/C 58 0.186 57 0.198 1.076 (0.717–1.617) 0.723 1.075 (0.715–1.615) 0.728
T/G-C/T 62 0.199 80 0.278 1.545 (1.057–2.257) 0.025 1.546 (1.058–2.260) 0.024
T/G-T/T 22 0.071 20 0.069 0.980 (0.523–1.837) 0.951 0.979 (0.522–1.835) 0.947
G/G-C/C 45 0.145 32 0.111 0.739 (0.455–1.200) 0.221 0.739 (0.455–1.201) 0.222
G/G-C/T 51 0.164 42 0.146 0.870 (0.558–1.357) 0.540 0.871 (0.558–1.357) 0.541
G/G-T/T 17 0.055 9 0.031 0.558 (0.245–1.272) 0.165 0.559 (0.244–1.276) 0.167
c.-468T>G – APEX1 (rs1760944) and c.2285T>C – PARP1 (rs1136410)
T/T-A/A 31 0.100 29 0.101 1.011 (0.593–1.725) 0.967 1.011 (0.593–1.724) 0.969
T/T-A/G 23 0.074 16 0.056 0.737 (0.381–1.424) 0.363 0.736 (0.381–1.423) 0.362
T/T-G/G 2 0.006 3 0.010 1.626 (0.270–9.803) 0.596 1.631 (0.270–9.835) 0.594
T/G-A/A 96 0.309 105 0.365 1.285 (0.915–1.805) 0.148 1.285 (0.913–1.808) 0.150
T/G-A/G 44 0.141 45 0.156 1.124 (0.716–1.763) 0.612 1.128 (0.718–1.772) 0.603
T/G-G/G 2 0.006 7 0.024 3.849 (0.793–18.681) 0.094 3.845 (0.792–18.666) 0.095
G/G-A/A 74 0.238 57 0.198 0.790 (0.535–1.167) 0.237 0.791 (0.535–1.169) 0.239
G/G-A/G 36 0.116 21 0.073 0.601 (0.342–1.056) 0.077 0.601 (0.342–1.057) 0.077
G/G-G/G 3 0.010 5 0.017 1.814 (0.430–7.659) 0.418 1.810 (0.428–7.645) 0.420
c.-468T>G – APEX1 (rs1760944) and c.-441G>A – FEN1 (rs174538)
T/T-A/A 0 – 0 – – – – –
T/T-A/G 29 0.093 23 0.080 0.844 (0.476–1.496) 0.561 0.838 (0.471–1.491) 0.548
T/T-G/G 27 0.087 25 0.087 1.000 (0.566–1.767) 1.000 1.004 (0.567–1.777) 0.990
T/G-A/A 0 – 0 – – – – –
T/G-A/G 67 0.215 64 0.222 1.041 (0.706–1.533) 0.841 1.041 (0.706–1.534) 0.840
T/G-G/G 75 0.241 93 0.323 1.501 (1.049–2.148) 0.026 1.500 (1.048–2.148) 0.027
G/G-A/A 0 – 0 – – – – –
G/G-A/G 55 0.177 32 0.111 0.582 (0.364–0.930) 0.024 0.582 (0.364–0.931) 0.024
G/G-G/G 58 0.186 51 0.177 0.939 (0.619–1.423) 0.765 0.939 (0.619–1.423) 0.766
c.-7C>T – LIG1 (rs20579) and c.*50C>T – LIG3 (rs1052536)
A/A-C/C 0 – 0 – – – – –
A/A-C/T 2 0.006 4 0.014 2.176 (0.396–11.971) 0.371 2.187 (0.397–12.046) 0.369
A/A-T/T 1 0.003 3 0.010 3.263 (0.338–31.550) 0.307 3.264 (0.338–31.560) 0.307
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Combined 
genotype
Control (n=311) Depression (n=288) Crude OR 
(95% CI)
p
Adjusted OR* 
(95% CI)
p
Number Frequency Number Frequency
A/G-C/C 12 0.039 20 0.069 1.859 (0.892–3.876) 0.098 1.858 (0.891–3.873) 0.098
A/G-C/T 42 0.135 31 0.108 0.773 (0.471–1.267) 0.306 0.773 (0.471–1.267) 0.307
A/G-T/T 19 0.061 14 0.049 0.785 (0.386–1.597) 0.504 0.785 (0.386–1.597) 0.504
G/G-C/C 44 0.141 59 0.205 1.563 (1.019–2.400) 0.041 1.564 (1.019–2.400) 0.041
G/G-C/T 122 0.392 101 0.351 0.837 (0.600–1.166) 0.293 0.836 (0.599–1.165) 0.290
G/G-T/T 69 0.222 56 0.194 0.847 (0.570–1.258) 0.410 0.847 (0.570–1.260) 0.413
c.-7C>T – LIG1 (rs20579) and c.*83A>C – LIG3 (rs4796030)
A/A-A/A 0 – 0 – – –
A/A-A/C 0 – 2 0.007 – –
A/A-C/C 3 0.010 5 0.017 1.814 (0.430–7.659) 0.418 1.821 (0.431–7.694) 0.415
A/G-A/A 6 0.019 13 0.045 2.403 (0.901–6.409) 0.080 2.402 (0.901–6.407) 0.080
A/G-A/C 34 0.109 25 0.087 0.774 (0.450–1.333) 0.356 0.775 (0.450–1.335) 0.359
A/G-C/C 33 0.106 27 0.094 0.871 (0.510–1.489) 0.615 0.870 (0.508–1.487) 0.610
G/G-A/A 25 0.080 40 0.139 1.845 (1.088–3.128) 0.023 1.851 (1.091–3.139) 0.022
G/G-A/C 101 0.325 93 0.323 0.992 (0.704–1.397) 0.962 0.992 (0.704–1.397) 0.963
G/G-C/C 109 0.350 83 0.288 0.750 (0.531–1.060) 0.103 0.749 (0.530–1.059) 0.101
c.-7C>T – LIG1 (rs20579) and c.2285T>C – PARP1 (rs1136410)
A/A-A/A 1 0.003 2 0.007 2.168 (0.196–24.036) 0.528 2.151 (0.193–23.970) 0.534
A/A-A/G 2 0.006 4 0.014 2.176 (0.396–11.971) 0.371 2.202 (0.399–12.159) 0.365
A/A-G/G 0 – 1 0.003 – – – –
A/G-A/A 49 0.158 46 0.160 1.016 (0.655–1.576) 0.942 1.016 (0.655–1.575) 0.945
A/G-A/G 24 0.077 17 0.059 0.750 (0.394–1.427) 0.381 0.751 (0.395–1.428) 0.382
A/G-G/G 0 – 2 0.007 – – – –
G/G-A/A 151 0.486 143 0.497 1.045 (0.758–1.440) 0.788 1.044 (0.758–1.439) 0.792
G/G-A/G 77 0.248 61 0.212 0.817 (0.557–1.197) 0.299 0.817 (0.557–1.199) 0.302
G/G-G/G 7 0.023 12 0.042 1.888 (0.733–4.864) 0.188 1.886 (0.732–4.859) 0.189
c.-7C>T – LIG1 (rs20579) and c.-441G>A – FEN1 (rs174538)
A/A-A/A 0 – 0 – – – – –
A/A-A/G 2 0.006 5 0.017 2.730 (0.525–14.181) 0.232 2.730 (0.525–14.181) 0.232
A/A-G/G 1 0.003 2 0.007 2.168 (0.196–24.036) 0.528 2.161 (0.195–23.970) 0.530
A/G-A/A 0 – 0 – – – – –
A/G-A/G 37 0.119 19 0.066 0.523 (0.293–0.933) 0.028 0.523 (0.293–0.932) 0.028
A/G-G/G 36 0.116 46 0.160 1.452 (0.908–2.321) 0.119 1.452 (0.908–2.321) 0.119
G/G-A/A 0 – 0 – – – – –
G/G-A/G 112 0.360 95 0.330 0.875 (0.624–1.226) 0.437 0.874 (0.624–1.225) 0.435
G/G-C/C 123 0.395 121 0.420 1.107 (0.799–1.535) 0.540 1.108 (0.800–1.535) 0.538
c.*50C>T – LIG3 (rs1052536) and c.580C>T – XRCC1 (rs1799782)
C/C-G/G 47 0.151 63 0.219 1.573 (1.036–2.388) 0.034 1.572 (1.036–2.387) 0.034
C/C-G/A 9 0.029 14 0.049 1.715 (0.730–4.024) 0.216 1.714 (0.730–4.023) 0.216
C/C-A/A 0 - 2 0.007 – – – –
C/T-G/G 152 0.489 122 0.424 0.769 (0.557–1.061) 0.110 0.769 (0.557–1.062) 0.110
C/T-G/A 13 0.042 14 0.049 1.171 (0.541–2.536) 0.688 1.167 (0.5358–2.534) 0.696
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Combined 
genotype
Control (n=311) Depression (n=288) Crude OR 
(95% CI)
p
Adjusted OR* 
(95% CI)
p
Number Frequency Number Frequency
C/T-A/A 1 0.003 0 – – – – –
T/T-G/G 75 0.241 59 0.205 0.811 (0.551–1.193) 0.287 0.811 (0.551–1.196) 0.291
T/T-G/A 14 0.045 14 0.049 1.084 (0.508–2.315) 0.835 1.081 (0.505–2.311) 0.841
T/T-A/A 0 – 0 – – – – –
c.*50C>T – LIG3 (rs1052536) and c.1196A>G – XRCC1 (rs25487)
C/C-C/C 23 0.074 32 0.111 1.565 (0.893–2.745) 0.118 1.565 (0.893–2.745) 0.118
C/C-C/T 25 0.080 37 0.128 1.686 (0.988–2.879) 0.056 1.686 (0.988–2.879) 0.056
C/C-T/T 8 0.026 10 0.035 1.362 (0.530–3.501) 0.521 1.361 (0.530–3.498) 0.522
C/T-C/C 65 0.209 46 0.160 0.719 (0.474–1.092) 0.122 0.715 (0.470–1.087) 0.117
C/T-C/T 74 0.238 72 0.250 1.068 (0.735–1.550) 0.731 1.069 (0.736–1.553) 0.726
C/T-T/T 27 0.087 18 0.063 0.701 (0.378–1.303) 0.261 0.702 (0.378–1.303) 0.262
T/T-C/C 42 0.135 30 0.104 0.745 (0.452–1.226) 0.247 0.745 (0.453–1.228) 0.249
T/T-C/T 39 0.125 36 0.125 0.996 (0.614–1.617) 0.988 0.996 (0.614–1.617) 0.987
T/T-T/T 8 0.026 7 0.024 0.944 (0.338–2.636) 0.912 0.947 (0.339–2.651) 0.918
c.*50C>T – LIG3 (rs1052536) and c.2285T>C – PARP1 (rs1136410)
C/C-A/A 39 0.125 57 0.198 1.721 (1.105–2.681) 0.016 1.720 (1.104–2.681) 0.017
C/C-A/G 17 0.055 17 0.059 1.085 (0.543–2.168) 0.818 1.086 (0.543–2.170) 0.815
C/C-G/G 0 - 5 0.017 – – – –
C/T-A/A 108 0.347 89 0.309 0.841 (0.597–1.183) 0.320 0.839 (0.595–1.181) 0.314
C/T-A/G 52 0.167 40 0.139 0.803 (0.514–1.257) 0.338 0.804 (0.514–1.259) 0.341
C/T-G/G 6 0.019 7 0.024 1.266 (0.421–3.813) 0.675 1.263 (0.419–3.807) 0.678
T/T-A/A 54 0.174 45 0.156 0.881 (0.572–1.359) 0.567 0.882 (0.572–1.360) 0.570
T/T-A/G 34 0.109 25 0.087 0.774 (0.450–1.333) 0.356 0.775 (0.450–1.335) 0.359
T/T-G/G 1 0.003 3 0.010 3.263 (0.338–31.550) 0.307 3.250 (0.336–31.466) 0.309
c.*50C>T – LIG3 (rs1052536) and c.-441G>A – FEN1 (rs174538)
C/C-A/A 0 – 0 – – – – –
C/C-A/G 29 0.093 31 0.108 1.173 (0.688–2.000) 0.558 1.172 (0.687–1.999) 0.559
C/C-G/G 27 0.087 48 0.167 2.104 (1.274–3.475) 0.004 2.104 (1.274–3.475) 0.004
C/T-A/A 0 – 0 – – – – –
C/T-A/G 86 0.277 58 0.201 0.660 (0.451–0.965) 0.032 0.658 (0.449–0.963) 0.031
C/T-G/G 80 0.257 78 0.271 1.072 (0.746–1.543) 0.706 1.073 (0.746–1.544) 0.704
T/T-A/A 0 - 0 - – – – –
T/T-A/G 36 0.116 30 0.104 0.888 (0.532–1.484) 0.651 0.890 (0.532–1.489) 0.658
T/T-G/G 53 0.170 43 0.149 0.854 (0.551–1.325) 0.482 0.854 (0.551–1.324) 0.481
c.*83A>C – LIG3 (rs4796030) and c.580C>T – XRCC1 (rs1799782)
A/A-G/G 25 0.080 43 0.149 2.008 (1.192–3.383) 0.009 2.015 (1.195–3.398) 0.009
A/A-G/A 6 0.019 9 0.031 1.640 (0.576–4.666) 0.354 1.637 (0.575–4.660) 0.356
A/A-A/A 0 – 1 0.003 – – – –
A/C-G/G 124 0.399 106 0.368 0.878 (0.631–1.222) 0.441 0.879 (0.632–1.223) 0.444
A/C-G/A 10 0.032 13 0.045 1.423 (0.614–3.297) 0.411 1.423 (0.614–3.297) 0.411
A/C-A/A 1 0.003 1 0.003 1.080 (0.067–17.349) 0.957 1.068 (0.066–14.231) 0.963
C/C-G/G 125 0.402 95 0.330 0.732 (0.524–1.023) 0.068 0.732 (0.524–1.023) 0.068
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Combined 
genotype
Control (n=311) Depression (n=288) Crude OR 
(95% CI)
p
Adjusted OR* 
(95% CI)
p
Number Frequency Number Frequency
C/C-G/A 20 0.064 20 0.069 1.086 (0.572–2.063) 0.801 1.082 (0.567–2.061) 0.812
C/C-A/A 0 – 0 – – – – –
c.*83A>C – LIG3 (rs4796030) and c.1196A>G – XRCC1 (rs25487)
A/A-C/C 13 0.042 22 0.076 1.896 (0.937–3.838) 0.075 1.897 (0.937–3.841) 0.075
A/A-C/T 13 0.042 27 0.094 2.371 (1.199–4.691) 0.013 2.374 (1.200–4.698) 0.013
A/A-T/T 5 0.016 4 0.014 0.862 (0.229–3.242) 0.826 0.865 (0.230–3.259) 0.831
A/C-C/C 51 0.164 39 0.135 0.798 (0.508–1.254) 0.329 0.796 (0.507–1.252) 0.324
A/C-C/T 59 0.190 63 0.219 1.196 (0.803–1.781) 0.378 1.199 (0.805–1.787) 0.372
A/C-T/T 25 0.080 18 0.063 0.763 (0.407–1.430) 0.398 0.764 (0.407–1.432) 0.401
C/C-C/C 66 0.212 47 0.163 0.724 (0.478–1.095) 0.126 0.723 (0.478–1.095) 0.126
C/C-C/T 66 0.212 55 0.191 0.876 (0.587–1.308) 0.518 0.875 (0.586–1.306) 0.513
C/C-T/T 13 0.042 13 0.045 1.084 (0.494–2.378 0.841 1.082 (0.493–2.375) 0.844
c.*83A>C – LIG3 (rs4796030) and c.2285T>C – PARP1 (rs1136410)
A/A-A/A 19 0.061 37 0.128 2.265 (1.271–4.039) 0.006 2.268 (1.272–4.044) 0.006
A/A-A/G 12 0.039 14 0.049 1.273 (0.579–2.800) 0.548 1.275 (0.579–2.805) 0.546
A/A-G/G 0 – 2 0.007 – – – –
A/C-A/A 93 0.299 78 0.271 0.871 (0.610–1.242) 0.445 0.870 (0.610–1.242) 0.443
A/C-A/G 37 0.119 37 0.128 1.092 (0.671–1.776) 0.724 1.097 (0.672–1.789) 0.712
A/C-G/G 5 0.016 5 0.017 1.081 (0.310–3.774) 0.902 1.079 (0.309–3.768) 0.905
C/C-A/A 89 0.286 76 0.264 0.894 (0.624–1.281) 0.542 0.893 (0.623–1.279) 0.536
C/C-A/G 54 0.174 31 0.108 0.574 (0.357–0.922) 0.022 0.574 (0.357–0.922) 0.022
C/C-G/G 2 0.006 8 0.028 4.414 (0.930–20.963) 0.062 4.408 (0.928–20.939) 0.062
c.*83A>C – LIG3 (rs4796030) and c.-441G>A – FEN1 (rs174538)
A/A-A/A 0 – 0 – – – – –
A/A-A/G 18 0.058 18 0.063 1.085 (0.553–2.129) 0.812 1.089 (0.554–2.139) 0.805
A/A-G/G 13 0.042 35 0.122 3.171 (1.642–6.125) < 0.001 3.171 (1.642–6.124) <0.001
A/C-A/A 0 – 0 – – – – –
A/C-A/G 71 0.228 49 0.170 0.693 (0.462–1.040) 0.076 0.692 (0.461–1.039) 0.076
A/C-G/G 64 0.206 71 0.247 1.263 (0.860–1.854) 0.234 1.266 (0.862–1.860) 0.229
C/C-A/A 0 – 0 - – – – –
C/C-A/G 62 0.199 52 0.181 0.885 (0.588–1.332) 0.558 0.884 (0.587–1.331) 0.555
C/C-G/G 83 0.267 63 0.219 0.769 (0.528–1.120) 0.171 0.768 (0.527–1.119) 0.169
c.580C>T – XRCC1 (rs1799782) and c.2285T>C – PARP1 (rs1136410)
G/G-A/A 178 0.572 160 0.556 0.934 (0.676–1.290) 0.679 0.934 (0.676–1.291) 0.679
G/G-A/G 90 0.289 72 0.250 0.819 (0.570–1.176) 0.279 0.819 (0.570–1.178) 0.282
G/G-G/G 6 0.019 12 0.042 2.210 (0.818–5.968) 0.118 2.208 (0.818–5.964) 0.118
G/A-A/A 22 0.071 30 0.104 1.527 (0.859–2.715) 0.149 1.528 (0.857–2.727) 0.151
G/A-A/G 13 0.042 10 0.035 0.825 (0.356–1.911) 0.653 0.825 (0.356–1.912) 0.654
G/A-G/G 1 0.003 2 0.007 2.168 (0.196–24.036) 0.528 2.161 (0.195–23.970) 0.530
A/A-A/A 1 0.003 1 0.003 1.080 (0.067–17.349) 0.957 1.068 (0.066–17.231) 0.963
A/A-A/G 0 – 0 – – – – –
A/A-G/G 0 – 1 0.003 – – – –
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Combined 
genotype
Control (n=311) Depression (n=288) Crude OR 
(95% CI)
p
Adjusted OR* 
(95% CI)
p
Number Frequency Number Frequency
c.580C>T – XRCC1 (rs1799782) and c.-441G>A – FEN1 (rs174538)
G/G-A/A 0 – 0 – – – – –
G/G-A/G 135 0.434 101 0.351 0.704 (0.506–0.979) 0.037 0.704 (0.506–0.979) 0.037
G/G-G/G 139 0.447 143 0.497 1.220 (0.885–1.683) 0.225 1.224 (0.887–1.689) 0.219
G/A-A/A 0 – 0 – – – – –
G/A-A/G 16 0.051 17 0.059 1.157 (0.573–2.335) 0.685 1.156 (0.573–2.334) 0.685
G/A-G/G 20 0.064 25 0.087 1.383 (0.751–2.548) 0.298 1.382 (0.747–2.556) 0.303
A/A-A/A 0 - 0 - – – – –
A/A-A/G 0 - 1 0.003 – – – –
A/A-G/G 1 0.003 1 0.003 1.080 (0.067–17.349) 0.957 1.080 (0.067–17.354) 0.956
c.1196A>G – XRCC1 (rs25487) and c.2285T>C – PARP1 (rs1136410)
C/C-A/A 84 0.270 77 0.267 0.986 (0.687–1.416) 0.940 0.984 (0.685–1.414) 0.930
C/C-A/G 43 0.138 27 0.094 0.645 (0.387–1.074) 0.092 0.645 (0.387–1.075) 0.093
C/C-G/G 3 0.010 4 0.014 1.446 (0.321–6.517) 0.631 1.449 (0.321–6.532) 0.629
C/T-A/A 88 0.283 90 0.313 1.152 (0.811–1.636) 0.429 1.152 (0.811–1.636) 0.429
C/T-A/G 47 0.151 45 0.156 1.040 (0.667–1.622) 0.862 1.042 (0.668–1.625) 0.858
C/T-G/G 3 0.010 10 0.035 3.693 (1.006–13.556) 0.049 3.691 (1.006–13.549) 0.049
T/T-A/A 29 0.093 24 0.083 0.884 (0.502–1.557) 0.670 0.884 (0.502–1.557) 0.670
T/T-A/G 13 0.042 10 0.035 0.825 (0.356–1.911) 0.653 0.827 (0.356–1.920) 0.659
T/T-G/G 1 0.003 1 0.003 1.080 (0.067–17.349) 0.957 1.068 (0.066–17.231) 0.963
c.1196A>G – XRCC1 (rs25487) and c.-441G>A – FEN1 (rs174538)
C/C-A/A 0 – 0 – – – – –
C/C-A/G 66 0.212 48 0.167 0.742 (0.492–1.121) 0.157 0.739 (0.489–1.118) 0.152
C/C-G/G 64 0.206 60 0.208 1.016 (0.684–1.508) 0.939 1.016 (0.684–1.509) 0.937
C/T-A/A 0 – 0 – – – – –
C/T-A/G 59 0.190 57 0.198 1.054 (0.703–1.581) 0.800 1.055 (0.703–1.583) 0.795
C/T-G/G 79 0.254 88 0.306 1.292 (0.903–1.848) 0.160 1.292 (0.904–1.848) 0.160
T/T-A/A 0 – 0 – – – – –
T/T-A/G 26 0.084 14 0.049 0.560 (0.286–1.095) 0.090 0.561 (0.287–1.097) 0.091
T/T-G/G 17 0.055 21 0.073 1.360 (0.703–2.633) 0.361 1.360 (0.702–2.632) 0.362
c.2285T>C – PARP1 (rs1136410) and c.-441G>A – FEN1 (rs174538)
A/A-A/A 0 – 0 – – – – –
A/A-A/G 100 0.322 78 0.271 0.784 (0.551–1.115) 0.175 0.782 (0.550–1.113) 0.172
A/A-G/G 101 0.325 113 0.392 1.343 (0.960–1.877) 0.085 1.342 (0.960–1.876) 0.085
A/G-A/A 0 – 0 – – – – –
A/G-A/G 47 0.151 36 0.125 0.802 (0.503–1.280) 0.356 0.803 (0.503–1.283) 0.359
A/G-G/G 56 0.180 46 0.160 0.866 (0.564–1.328) 0.508 0.866 (0.565–1.329) 0.511
G/G-A/A 0 – 0 – – – – –
G/G-A/G 4 0.013 5 0.017 1.356 (0.361–5.100) 0.652 1.352 (0.359–5.088) 0.656
G/G-G/G 3 0.010 10 0.035 3.693 (1.006–13.556) 0.049 3.699 (1.007–13.578) 0.049
* OR adjusted for sex. p<0.05 along with corresponding ORs are in bold; p<0.012 along with corresponding ORs are in bold and italic.
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